| Date Filed | Type | Description |
| 03/01/2023 |
4
| WADE JEFFREY L (President and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 30,255 shares
@ $2.17, valued at
$65.7k
Exercised 30,467 restricted stock units
@ $0
Exercised 11,176 restricted stock units
@ $0
Exercised 37,273 restricted stock units
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| WADE JEFFREY L (President and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 335,470 options to buy
@ $3.2, valued at
$1.1M
Granted 111,820 restricted stock units
@ $0 |
|
| 02/11/2022 |
5
| WADE JEFFREY L (President and CFO) has filed a Form 5 on LEXICON PHARMACEUTICALS, INC. |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2020 |
4
| WADE JEFFREY L (EVP, Corp Adm Affairs and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 26,525 shares
@ $0
Paid exercise price by delivering 9,651 shares
@ $1.96, valued at
$18.9k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 03/02/2018 |
4
| WADE JEFFREY L (EVP, Corp Adm Affairs and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 6,133 shares
@ $8.53, valued at
$52.3k
Exercised 2,929 restricted stock units
@ $0
Exercised 5,807 restricted stock units
@ $0
Exercised 4,495 restricted stock units
@ $0
Exercised 2,797 restricted stock units
@ $0 |
|
| 02/12/2018 |
4
| WADE JEFFREY L (EVP, Corp Adm Affairs and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 28,665 restricted stock units
@ $0
Granted 79,550 options to buy
@ $9.79, valued at
$778.8k
|
|
| 02/12/2018 |
5
| WADE JEFFREY L (EVP, Corp Adm Affairs and CFO) has filed a Form 5 on LEXICON PHARMACEUTICALS, INC. |
| 11/14/2017 |
4
| WADE JEFFREY L (EVP, Corp Adm Affairs and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 2,000 shares
@ $9.4809, valued at
$19k
|
|
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2013 |
4
| WADE JEFFREY L (EVP, Corp Dev and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 10,461 shares
@ $1.98, valued at
$20.7k
Exercised 18,750 options to buy
@ $0
Exercised 19,500 options to buy
@ $0 |
|
| 02/12/2013 |
4
| WADE JEFFREY L (EVP, Corp Dev and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Granted 68,000 options to buy
@ $0
Granted 272,000 options to buy
@ $2.09, valued at
$568.5k
|
|
| 03/01/2012 |
4
| WADE JEFFREY L (EVP, Corp Dev and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 4,959 shares
@ $1.78, valued at
$8.8k
Exercised 18,750 options to buy
@ $0 |
|
| 02/25/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2010 |
4
| WADE JEFFREY L (EVP, Corp Dev and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Granted 100,000 options to buy
@ $1.52, valued at
$152k
|
|
| 02/17/2010 |
4
| WADE JEFFREY L (EVP, General Counsel) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 7,314 shares
@ $1.91, valued at
$14k
Granted 375,000 options to buy
@ $1.9, valued at
$712.5k
Granted 31,600 options to buy
@ $0 |
|
| 08/14/2009 |
4
| WADE JEFFREY L (EVP, Gen. Counsel) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE |